Unity Software Q1 2026 Results Beat Guidance

Unity Software Q1 2026 results topped guidance as Vector drove revenue and adjusted EBITDA above outlook, sending shares higher and prompting re-rating.

March 27, 2026·2 min read
View all news articles
Flat-vector cover of a game-engine server merging into a neural circuit to reflect Unity Software Q1 2026 results momentum.

KEY TAKEAWAYS

  • Preliminary Q1 2026 revenue $505-$508 million and adjusted EBITDA $130-$135 million exceeded guidance.
  • Unity Vector comprised roughly 80% of Strategic Grow and grew 15% sequentially.
  • The company will sunset the ironSource Ads Network April 30, 2026 and pursue a Supersonic divestiture.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Unity Software (U) reported preliminary first-quarter 2026 results on March 26, 2026, exceeding guidance and boosting its stock after management announced plans to sunset the ironSource Ads Network and engage a financial adviser to pursue a Supersonic divestiture. The company is shifting focus toward its higher-margin Vector and Create segments.

Preliminary Results and Vector Growth

Unity’s preliminary Q1 2026 total revenue ranged from $505 million to $508 million, surpassing prior guidance of $480 million to $490 million and marking 17% year-over-year growth. Adjusted EBITDA, a proxy for operating profit, came in between $130 million and $135 million, above the previous range of $105 million to $110 million, up 58% year-over-year and implying a 26% margin.

Strategic revenue totaled $431 million, up 34% year-over-year. Within this, Grow revenue reached $352 million, while Create revenue was $155 million. Unity Vector, the company’s artificial intelligence advertising platform, accounted for roughly 80% of Strategic Grow revenue and grew 15% sequentially in the quarter. Matt Bromberg, president and chief executive, said, “Unity Vector continues to deliver robust growth each quarter.”

Divestitures and Market Reaction

Management said it will sunset the ironSource Ads Network effective April 30, 2026, expecting minimal revenue contribution from the business after Q1. The company has engaged a financial adviser to explore a sale of Supersonic game publishing as it prioritizes Vector and Create. Unity said these moves will accelerate revenue growth and improve adjusted EBITDA and margins.

The preliminary results are unaudited and subject to closing procedures and potential adjustments. After the March 26 press release at 4:05 p.m. ET, shares rose about 12.5% in after-hours trading to $19.27 from a $17.13 close and continued to gain in early trading on March 27, with intraday increases reported between 10% and 17%. Analysts responded with more constructive coverage and higher price targets.

Management emphasized that exiting nonstrategic ad businesses will enhance revenue growth and profitability.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

Argan Q4 Results Highlight Backlog and Cash

Argan Q4 Results Highlight Backlog and Cash

Argan Q4 results on March 26 showed stronger margins, a $2.9 billion backlog and a higher dividend, supporting balance sheet strength and trader interest.

Nvidia Stock Falls to AI-Era Low

Nvidia Stock Falls to AI-Era Low

Nvidia stock fell to AI-era lows amid a pullback; $35.6B Q4 data-center revenue and a $1T hyperscaler backlog support traders before May 20 earnings.

Meta Entergy Louisiana Deal Promises $2B Savings

Meta Entergy Louisiana Deal Promises $2B Savings

Meta Entergy Louisiana deal funds plants and transmission for the Hyperion data center and shifts costs, reshaping investor exposure to regional utilities.

Carnival Cuts Profit Outlook as Fuel Costs Surge

Carnival Cuts Profit Outlook as Fuel Costs Surge

Carnival cuts profit outlook after rising fuel costs squeeze margins while record quarterly results and a $2.5 billion buyback complicate trader positioning.

AstraZeneca Tozorakimab Tops Late-Stage COPD Trials

AstraZeneca Tozorakimab Tops Late-Stage COPD Trials

AstraZeneca tozorakimab met primary endpoints in late-stage OBERON and TITANIA, spurring investor optimism ahead of full data presentation.

Novartis Acquires Excellergy for Up to $2 Billion

Novartis Acquires Excellergy for Up to $2 Billion

Novartis Acquires Excellergy, adding Exl-111 to its allergy pipeline and refocusing traders on IgE pipeline upside ahead of an expected H2 2026 close.